Kentucky Cancer Center Busted for Buying Overseas Chemo

HemOnc_Ctr_full.jpeg

Hematology and Oncology Center (HOC) PLLC of Somerset, Kentucky has pleaded guilty to federal charges that the firm purchased and sold unapproved and improperly labeled chemotherapy drugs.

Natarajan Murugesan, HOC's former office manager, has also pleaded guilty to assisting with these activities--violations of the Federal Food, Drug, and Cosmetic Act.

Agents from the FDA’s Office of Criminal Investigations led this investigation with assistance from the U.S. Department of Health and Human Services’ Office of Inspector General.

"The FDA commends the U.S. Attorney’s Office, Eastern District of Kentucky, for pursuing these allegations and for helping protect U.S. consumers from potentially receiving counterfeit, ineffective, or contaminated medicines," said Philip Walsky, acting director of the FDA’s Office of Criminal Investigations. "The FDA is committed to ensuring that consumers have access to high-quality drugs that are safe and effective."

The criminal charges relate to a civil settlement agreed to in January 2014 by HOC, Murugesan, and N Mullai, M.D. Dr. Mullai was not charged criminally. Under the earlier civil settlement, HOC, Murugesan, and Mullai agreed to pay $2 million (plus interest) to resolve charges that they violated the False Claims Act. These charges included submitting false claims to the Medicare program for misbranded, unapproved chemotherapy drugs administered through HOC’s Somerset, Kentucky, clinic.

HOC obtained substantial amounts of chemotherapy drugs and other cancer treatment drugs from a foreign drug distributor in Canada operating under the name Quality Specialty Products (QSP).

These drugs were obtained from international locations including Turkey, India, and the European Union. Typically, the drugs arrived at HOC with labels and dosage instructions in foreign languages. In 2012, the FDA sent letters to medical practices, including HOC, alerting them that the cancer medicines they purchased from QSP were unapproved and potentially counterfeit.

Source: FDA

 

The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.